Rare Dermatology News

Advertisement

Spotlight On

Chronic Neutropenia

Chronic neutropenia is typically defined as neutropenia that lasts for at least for 3 months and is not attributable to drugs or a specific genetic, infectious, inflammatory, autoimmune or a malignant cause

Prevalence

2/100,000

1,000–6,000

US Estimated

1,500–9,000

Europe Estimated

Age of Onset

All ages

ICD-10

D70.9

Inheritance

Autosomal dominant

Autosomal recessive

Mitochondrial/Multigenic

X-linked dominant

X-linked recessive

Rare View

Chronic Neutropenia is a condition characterized by persistently low levels of neutrophils, a type of white blood cell essential for fighting bacterial and fungal infections.

5 Facts you should know

FACT

1

Chronic neutropenia is defined by persistent neutrophil counts <1500/μL for over 3 months, often with intermittent infections or mucosal ulcers

FACT

2

Congenital neutropenia is frequently linked to ELANE or HAX1 mutations; patients may present in infancy with life-threatening infections

FACT

3

Cyclic neutropenia typically follows a 21-day pattern of neutrophil decline and spontaneous recovery; symptoms often coincide with nadir

FACT

4

Autoimmune neutropenia of childhood may resolve spontaneously; diagnosis is supported by anti-neutrophil antibodies

FACT

5

Hematology-guided G-CSF therapy remains the cornerstone for reducing infection frequency and maintaining neutrophil levels in high-risk patients

Chronic neutropenia is also known as...

Chronic neutropenia is also known as:

  • Severe Congenital Neutropenia (SCN)

  • Cyclic Neutropenia

  • Kostmann Syndrome

  • Chronic Idiopathic Neutropenia

What’s your Rare IQ?

A patient with congenital neutropenia is most at risk for which complication if untreated?

 

Common signs and symptoms

Recurrent fevers

Mouth ulcers

Gingivitis and periodontitis

Skin abscesses

Proportionate short stature

Congenital cataracts and other eye anomalies

Airway malformations

Breathing difficulties

Current treatments

G-CSF (Granulocyte-Colony Stimulating Factor)

e.g., filgrastim to stimulate neutrophil production

Antibiotics

for active or prophylactic infection management

Routine blood monitoring

to track neutrophil levels

Bone marrow transplant

considered in severe or unresponsive cases (especially SCN)

Good oral and skin hygiene

critical for preventing infections

Current treatments

[table “” not found /]